Searching...
9 results for “drug discovery”
...drug discovery, I mean, as you have alluded to, I think that the idea that we're going to be able to have kind of an end to end black box where you type in a patient profile and and disease and outcomes, the molecular design of a cure is purely scien
10:21 / 11:31
from transcript10:21 – 11:31
...AI drug discovery continues to increase, the number of drugs being produced will simply continue to increase. Creating novel drug molecules will almost, to some degree, become commodified. But what will become really critical then is actually trying
33:33 / 34:52
from transcript33:33 – 34:52
...a drug and try, can we design them from, from the get go? The thing about those properties in some of them, you know, you need to, you know, start having an understanding of the cell. And so that's on the one end kind of why we need that understandin
1:14:14 / 1:15:19
from transcript1:14:14 – 1:15:19
...drug discovery is it's a discovery problem. It's a search problem. And so people are really just sort of panning for gold in these massive yeast or phage libraries. Or alternatively, you might inject a mouse or a llama. You might, wait a couple of we
7:31 / 8:45
from transcript7:31 – 8:45
The first one, it's one thing to predict, you know, a single interaction, for example, like a single structure. It's another to like, you know, very effectively search a space, design space to produce something of value. What we found like sort of bu
1:02:59 / 1:04:05
from transcript1:02:59 – 1:04:05
...us to make drugs against targets and get them turned around faster. But I think the thing that we're really excited about and what's, I think, more important is the entire class of targets that this will unlock in the future,
8:20 / 9:24
from transcript8:20 – 9:24
...drug discovery are so, like, tightly interwoven, and, you know, that's that's really what we need these models to help accelerate.
39:05 / 40:10
from transcript39:05 – 40:10
...drug discovery. Okay. So I've got a protein I want whose function I want to alter. What is the ability to actually discover a new chemical entity or a new protein entity or nucleic acid entity that will actually interfere there, that will actually do
15:45 / 16:50
from transcript15:45 – 16:50
process that we've been talking about today. There's designing. There's the making. There's the testing. There's the approvals side of it. And, you know, I think the I I do think safety and efficacy as the kind of two pillars in the industry are the
41:15 / 42:25
from transcript41:15 – 42:25
Have a podcast?
Run your podcast through Clypt
Get ranked clips, hooks, and ready-to-post copy from your own episodes. Free to try.